var data={"title":"Signal-averaged electrocardiogram: Overview of technical aspects and clinical applications","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Signal-averaged electrocardiogram: Overview of technical aspects and clinical applications</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/contributors\" class=\"contributor contributor_credentials\">Sanjiv M Narayan, MD, PhD</a></dd><dd><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/contributors\" class=\"contributor contributor_credentials\">Michael E Cain, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/contributors\" class=\"contributor contributor_credentials\">Ary L Goldberger, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/contributors\" class=\"contributor contributor_credentials\">Brian C Downey, MD, FACC</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 19, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Over 300,000 individuals succumb to sudden cardiac death (SCD) per year in the United States alone, with the single biggest cause being ventricular tachycardia (VT) or ventricular fibrillation (VF) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/1\" class=\"abstract_t\">1</a>]. The approach to the prevention of SCD depends upon the identification of those patients who are most likely to have a VT or VF and the effectiveness of the available preventive measures. (See <a href=\"topic.htm?path=pathophysiology-and-etiology-of-sudden-cardiac-arrest\" class=\"medical medical_review\">&quot;Pathophysiology and etiology of sudden cardiac arrest&quot;</a> and <a href=\"topic.htm?path=incidence-of-and-risk-stratification-for-sudden-cardiac-death-after-acute-myocardial-infarction\" class=\"medical medical_review\">&quot;Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction&quot;</a>.)</p><p>The signal-averaged electrocardiogram (SAECG) is a noninvasive signal-processing technique to detect subtle abnormalities in the surface ECG, not visible to the naked eye, that are related to the pathophysiology underlying reentrant arrhythmias such as VT. The SAECG has most often been used to identify low-amplitude signals at the terminus of the QRS complex, referred to as &quot;ventricular late potentials.&quot; These late potentials represent delayed ventricular activation, which may reflect the presence of myocardial scar tissue and identify patients at increased risk for reentrant ventricular tachyarrhythmias [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/2\" class=\"abstract_t\">2</a>]. The SAECG has been studied in an effort to identify individuals at risk for SCD, particularly in the context of coronary artery disease, acute myocardial infarction (MI), and left ventricular dysfunction (<a href=\"image.htm?imageKey=CARD%2F80458\" class=\"graphic graphic_table graphicRef80458 \">table 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/3-6\" class=\"abstract_t\">3-6</a>]. However, the SAECG can also be useful in evaluating the risk for atrial arrhythmias, with a prolonged SAECG P wave, equivalent to &quot;atrial late potentials,&quot; which may potentially identify patients at risk for atrial fibrillation [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/7,8\" class=\"abstract_t\">7,8</a>].</p><p>In patients with the substrates for VT, slow conduction through myocardium disrupted by inflammation, edema, fibrosis, or scar tissue results in electrical potentials that extend beyond the activation time of normal surrounding myocardium but that are too small for detection on the surface ECG. The SAECG uses computerized averaging of ECG complexes during sinus rhythm to facilitate the detection of these small microvolt-level signals, which occur later than rapid ventricular activation and are termed late potentials. (See <a href=\"#H1256947621\" class=\"local\">'Techniques'</a> below.)</p><p>The SAECG is particularly useful in understanding the arrhythmic substrate and stratifying risk for ventricular tachyarrhythmias in patients with cardiomyopathies of various etiologies, most commonly in association with arrhythmogenic (right) ventricular cardiomyopathy [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/9\" class=\"abstract_t\">9</a>], but also in the context of coronary heart disease, healed MI, or left ventricular dysfunction. The clinical uses and technical aspects of the SAECG and the characteristics of late potentials will be reviewed here. Specific conditions in which the SAECG is more regularly used are discussed separately. (See <a href=\"topic.htm?path=arrhythmogenic-right-ventricular-cardiomyopathy-diagnostic-evaluation-and-diagnosis#H155582488\" class=\"medical medical_review\">&quot;Arrhythmogenic right ventricular cardiomyopathy: Diagnostic evaluation and diagnosis&quot;, section on 'Signal-averaged ECG'</a> and <a href=\"topic.htm?path=brugada-syndrome-clinical-presentation-diagnosis-and-evaluation#H241462918\" class=\"medical medical_review\">&quot;Brugada syndrome: Clinical presentation, diagnosis, and evaluation&quot;, section on 'Signal-averaged ECG'</a> and <a href=\"topic.htm?path=sustained-monomorphic-ventricular-tachycardia-clinical-manifestations-diagnosis-and-evaluation#H9\" class=\"medical medical_review\">&quot;Sustained monomorphic ventricular tachycardia: Clinical manifestations, diagnosis, and evaluation&quot;, section on 'Signal-averaged electrocardiogram'</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">DEFINITIONS AND EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H1427388704\"><span class=\"h2\">Definition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Late potentials are low-amplitude, high-frequency signals that are thought to reflect slow and fragmented myocardial conduction (<a href=\"image.htm?imageKey=CARD%2F72380\" class=\"graphic graphic_figure graphicRef72380 \">figure 1</a>). Late potentials are defined by three criteria (<a href=\"image.htm?imageKey=CARD%2F67428\" class=\"graphic graphic_waveform graphicRef67428 \">waveform 1</a>) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/10\" class=\"abstract_t\">10</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Total filtered QRS duration</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Voltage in the terminal portion of the QRS (usually the last 40 milliseconds)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Duration of the terminal QRS that is below a particular amplitude (usually 40 microvolts), called the late potential duration</p><p/><p>This definition of late potentials is empiric, yet has become validated over time by clinical observations. Notably, values for each parameter depend upon the type and frequency response of the filters used in the signal-averaging system. The most commonly used algorithms employ a 40- or 25-Hz high-pass filter. Using the 40-Hz filter, a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology suggested the following definition of late potentials [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/11\" class=\"abstract_t\">11</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Filtered QRS duration &gt;114 milliseconds</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Terminal (last 40 milliseconds) QRS root mean square voltage &lt;20 microvolts</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low-amplitude (&lt;40 microvolts) late potentials with duration &gt;38 milliseconds</p><p/><p>Despite this attempt at standardization, authors have used variations of these criteria, and definitions for spectral (frequency-domain) analysis of late potentials have not been formalized.</p><p class=\"headingAnchor\" id=\"H3410181775\"><span class=\"h2\">Epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This abnormal conduction, which may occur in regions of prior infarction, nonischemic scar, or fibrosis, provides a substrate for reentrant ventricular tachycardia (VT) (<a href=\"image.htm?imageKey=CARD%2F82329\" class=\"graphic graphic_figure graphicRef82329 \">figure 2</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/12,13\" class=\"abstract_t\">12,13</a>]. Late potentials are present in 6 percent of asymptomatic normal subjects, but their incidence increases progressively when examining patients with a recent myocardial infarction (MI) without VT, patients with a remote MI who have not had VT, and patients with a remote MI who have had sustained monomorphic VT. Accordingly, the prevalence of late potentials in patients with documented VT and coronary artery disease ranges from 70 to 92 percent, and the predictive value of late potentials for VT increases with the number of other clinical risk factors [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/14,15\" class=\"abstract_t\">14,15</a>].</p><p class=\"headingAnchor\" id=\"H3598201842\"><span class=\"h1\">MECHANISM OF VENTRICULAR ARRHYTHMIAS DUE TO LATE POTENTIALS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Late potentials are primarily used to reflect the presence of substrates for ventricular tachycardia (VT) rather than a dynamic predisposition to form a reentrant circuit. This is because reentrant arrhythmias require a critical balance between conduction delay and heterogeneous recovery of excitability [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/16\" class=\"abstract_t\">16</a>]. (See <a href=\"topic.htm?path=reentry-and-the-development-of-cardiac-arrhythmias\" class=\"medical medical_review\">&quot;Reentry and the development of cardiac arrhythmias&quot;</a>.)</p><p>Therefore, while late potentials reflect slow conduction related to arrhythmogenic substrates, episodes of VT initiation in such patients are uncommon in the absence of additional triggers such as ventricular premature beats, electrolyte abnormalities, increased circulating catecholamines, or ischemia. (See <a href=\"topic.htm?path=sustained-monomorphic-ventricular-tachycardia-clinical-manifestations-diagnosis-and-evaluation#H10017877\" class=\"medical medical_review\">&quot;Sustained monomorphic ventricular tachycardia: Clinical manifestations, diagnosis, and evaluation&quot;, section on 'Additional diagnostic evaluation'</a>.)</p><p>Despite their link with structural substrates, there is also evidence to suggest that late potentials may indicate dynamic predisposition to ventricular arrhythmias:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diurnal variations in late potentials correspond to those reported in both the incidence of myocardial infarction (MI) and in the relative resistance of acute MI to thrombolysis [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/17-19\" class=\"abstract_t\">17-19</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Despite variability in the characteristics of late potentials, they consistently correlate with the subsequent induction of VT [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/20\" class=\"abstract_t\">20</a>].</p><p/><p>There has been ongoing debate about whether variability in late potentials reflects a dynamic susceptibility to VT or influences such as autonomic tone without direct arrhythmogenic impact [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/21\" class=\"abstract_t\">21</a>]. The synergy between slow conduction and additional clinical triggers in initiating VT is supported by the improvement in predictive accuracy for VT when combining the SAECG with assessments of left ventricular ejection fraction, autonomic tone, the presence of complex ventricular ectopy on ambulatory ECG recordings, or ischemia on exercise testing [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/22-24\" class=\"abstract_t\">22-24</a>]. An evolving area of study is in correlating late potential on the ECG with intracardiac ventricular late potentials that are increasingly used as targets for the ablation of VT [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H1256947621\"><span class=\"h1\">TECHNIQUES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The electrical signals of interest that reflect delayed conduction through ventricular or atrial scar are minute (in the microvolt range) compared with the size of the QRS complex or P wave seen on a surface ECG. Although simple amplification of the ECG may reveal these signals, it also amplifies ambient noise, which typically masks the useful low-amplitude signals.</p><p>The SAECG is derived by computing the arithmetic mean of multiple ECG complexes. This process requires consistent signals between complexes while diminishing the more variable noise components, thus increasing the signal-to-noise ratio of cardiac potentials to enable detection of smaller (ie, microvolt-level) signals than would otherwise be discernible on visual inspection of the surface ECG [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/26\" class=\"abstract_t\">26</a>]. Signals from the His bundle as well as subtle abnormalities of atrial or ventricular complexes, anomalies not visualized on a surface ECG, are detectable using the SAECG [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/27,28\" class=\"abstract_t\">27,28</a>]. The ECG can be averaged over time (&quot;temporal averaging&quot;) or spatially, and this process has been further enhanced by digital filtering and spectral analysis.</p><p class=\"headingAnchor\" id=\"H3400462\"><span class=\"h2\">Acquiring the data</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The ideal number and configuration of ECG leads used to record the SAECG is unclear, but the most commonly used lead set uses three bipolar leads in a standard X, Y, and Z (orthogonal) arrangement (<a href=\"image.htm?imageKey=CARD%2F75403\" class=\"graphic graphic_figure graphicRef75403 \">figure 3</a>). In most cases, the averaging of 200 to 400 QRS complexes with the same morphology, over approximately three to seven minutes, is sufficient to record an adequate SAECG.</p><p>Signal filtering further augments signal detection of the SAECG and minimizes random noise that is not synchronized to the QRS complex. As an example, filters facilitate easy recognition of QRS onset and offset. They may also help with the detection of low-amplitude, high-frequency signals, such as late potentials or atrial activity, during the otherwise low-frequency or isoelectric ST segment.</p><p>The most commonly used filters are bidirectional filters. In this setup, the high-pass component removes low-frequency activity, such as that due to baseline drift of the ECG signal and low-frequency components of the ST segment and T waves. The low-pass components remove high-frequency noise, such as pectoral muscle components.</p><p class=\"headingAnchor\" id=\"H1270124523\"><span class=\"h2\">Temporal signal averaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most commonly applied SAECG method, temporal signal averaging, averages a number of QRS complexes over time [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/29\" class=\"abstract_t\">29</a>]. Beats are detected by computer algorithms, based on voltage thresholds or other criteria, then aligned by a constant feature of the signal, the &quot;fiducial&quot; (<a href=\"image.htm?imageKey=CARD%2F75403\" class=\"graphic graphic_figure graphicRef75403 \">figure 3</a> and <a href=\"image.htm?imageKey=CARD%2F67428\" class=\"graphic graphic_waveform graphicRef67428 \">waveform 1</a>) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/30\" class=\"abstract_t\">30</a>]. Once beats have been aligned, their arithmetic mean is taken. This process diminishes random noise that is not synchronized to the QRS complex. The disadvantage of this process is that oscillating, transient, or other signals that are not present in each beat are diluted by temporal averaging. An approach to retain this information is spatial averaging. (See <a href=\"#H355085444\" class=\"local\">'Spatial signal averaging'</a> below.)</p><p>Since averaging is performed until a &quot;noise floor&quot; is reached, the lower the initial baseline noise level, the fewer the number of beats required to generate the SAECG, and the better the resultant signal. However, in order to obtain a reliable averaged signal, only QRS complexes of similar beat-to-beat morphology should be analyzed. Thus, premature ventricular beats, aberrantly conducted beats, or grossly &quot;noisy&quot; beats are excluded from the analysis. An automated algorithm typically generates an &quot;acceptable&quot; template from the first few QRS complexes, then compares each successive beat for &quot;closeness of fit&quot; with the template before incorporating the beat into the average [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/31\" class=\"abstract_t\">31</a>].</p><p>Temporal signal averaging has some inherent limitations:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>This technique can only enhance signals that occur in a fixed relationship to the fiducial point. If there is significant variability in the morphology of late potentials from beat to beat, they may actually be considered to be &quot;noise&quot; and diminished by averaging.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ventricular late potentials can only be detected from the body surface when the fragmented activity outlasts the normal ventricular activation. Thus, in patients with bundle branch block, late potentials may be obscured by the delayed activation of normal ventricular myocardium [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/29\" class=\"abstract_t\">29</a>].</p><p/><p class=\"headingAnchor\" id=\"H355085444\"><span class=\"h2\">Spatial signal averaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>ECG spatial averaging involves the summation and averaging of electrical potentials simultaneously recorded from multiple pairs of closely spaced electrodes [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/32\" class=\"abstract_t\">32</a>]. This process allows a real-time, beat-by-beat analysis of individual QRS complexes but requires electrical shielding of the patient and equipment. The advantage of this technique over temporal signal averaging is that it allows assessment of irregular rhythms with changing conduction or signals that may oscillate or otherwise vary between beats. The disadvantage is that by averaging across spatial locations, it dilutes information specific to any one location.</p><p>Although often considered distinct from the SAECG, spatial averaging is the basis of Laplacian filtering embodied in electrodes used to record beat-to-beat dynamics of T-wave alternans [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/33\" class=\"abstract_t\">33</a>]. The principle of spatial averaging is also the basis for high-resolution body surface potential mapping that may detect the risk for sudden cardiac arrest or other arrhythmias [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/34,35\" class=\"abstract_t\">34,35</a>]. Finally, spatial averaging also allows dynamic changes to be evaluated after drug therapy, after ectopic beats, or after the onset of ischemia. (See <a href=\"topic.htm?path=t-wave-repolarization-alternans-technical-aspects\" class=\"medical medical_review\">&quot;T wave (repolarization) alternans: Technical aspects&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1026286081\"><span class=\"h2\">Other techniques</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Spectral analysis</strong> &ndash; Spectral analysis considers the QRS complex (or P wave) to be composed of multiple, simple waveforms, typically sinusoids. Spectral analysis thus decomposes the QRS complex or P wave into these constituent signals, represented by component frequencies and corresponding phase and amplitudes [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/36,37\" class=\"abstract_t\">36,37</a>]. Spectral decomposition is typically performed using Fourier analysis, although methods such as wavelet transform have also been successfully applied [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/28\" class=\"abstract_t\">28</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Spectrotemporal analysis</strong> &ndash; Spectrotemporal analysis is the combination of time- and frequency-domain techniques [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/38\" class=\"abstract_t\">38</a>]. This procedure presents the Fourier transform of multiple segments of the ECG signal, shifted in time as a three-dimensional plot of the magnitude of individual signal frequencies against time. Thus, this technique may overcome the disadvantages of temporal signal averaging by allowing identification of fractionated activity occurring within the QRS complex (eg, in patients with an intraventricular conduction delay or a bundle branch block).</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL SETTINGS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>SAECG abnormalities are associated with an increased risk of ventricular arrhythmias and cardiac and sudden death mortality in the following clinical settings:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ischemic heart disease (<a href=\"image.htm?imageKey=CARD%2F53211\" class=\"graphic graphic_table graphicRef53211 \">table 2</a>), including post-myocardial infarction (MI) and ischemic cardiomyopathy [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/39-41\" class=\"abstract_t\">39-41</a>]. (See <a href=\"#H1059290742\" class=\"local\">'Ischemic heart disease'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonischemic cardiomyopathies [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/42-44\" class=\"abstract_t\">42-44</a>]. (See <a href=\"#H4169264728\" class=\"local\">'Dilated cardiomyopathy'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arrhythmogenic right ventricular cardiomyopathy (ARVC) (<a href=\"image.htm?imageKey=CARD%2F70822\" class=\"graphic graphic_figure graphicRef70822 \">figure 4</a>) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/45-48\" class=\"abstract_t\">45-48</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Brugada syndrome [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/49-51\" class=\"abstract_t\">49-51</a>]. (See <a href=\"topic.htm?path=brugada-syndrome-clinical-presentation-diagnosis-and-evaluation\" class=\"medical medical_review\">&quot;Brugada syndrome: Clinical presentation, diagnosis, and evaluation&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noninvasive diagnosis of transplant rejection in cardiac allograft recipients [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/52,53\" class=\"abstract_t\">52,53</a>]. (See <a href=\"topic.htm?path=acute-cardiac-allograft-rejection-diagnosis\" class=\"medical medical_review\">&quot;Acute cardiac allograft rejection: Diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Identification of individuals with paroxysmal atrial fibrillation (AF) prone to frequent recurrences based upon abnormalities in the P-wave SAECG [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"#H3803091927\" class=\"local\">'P-wave SAECG and atrial fibrillation'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although abnormalities in the SAECG have been identified in divergent populations with a number of cardiac diseases [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/54-64\" class=\"abstract_t\">54-64</a>], there is little or no clinical role for SAECG in their management. </p><p/><p>Patients with an abnormal SAECG appear to be at prognostically greater risk of ventricular tachycardia (VT) or sudden cardiac arrest (SCA), but the SAECG is only one of many prognosticating factors for VT and has a limited role for guiding therapy in modern cardiology practice. We concur with the 2008 American Heart <span class=\"nowrap\">Association/American</span> College of <span class=\"nowrap\">Cardiology/Heart</span> Rhythm Society <span class=\"nowrap\">(AHA/ACC/HRS)</span> scientific statement on noninvasive risk stratification [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/65\" class=\"abstract_t\">65</a>] and the 2006 <span class=\"nowrap\">ACC/AHA/European</span> Society of Cardiology guidelines for management of patients with ventricular arrhythmias [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/66\" class=\"abstract_t\">66</a>], which concluded that the SAECG may be useful to identify patients at low risk for sudden cardiac death (SCD), but its routine use to identify patients at high risk for SCD is not yet adequately supported.</p><p class=\"headingAnchor\" id=\"H1059290742\"><span class=\"h2\">Ischemic heart disease</span></p><p class=\"headingAnchor\" id=\"H4277501083\"><span class=\"h3\">Patients with prior VT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with sustained VT or ventricular fibrillation (VF), with or without coronary heart disease, will be treated with an implantable cardioverter-defibrillator (ICD) for secondary prevention of SCD. In such patients, further risk stratification testing including the SAECG is not likely to impact management. Because of this, we do not routinely perform SAECG in all patients with ischemic heart disease and documented VT or VF.</p><p>Abnormalities on the SAECG are common among patients with ischemic heart disease and prior MI, with a notable difference between patients with and without VT. SAECG abnormalities are present in up to 93 percent of those with a history of VT, compared with only 18 to 33 percent without prior VT [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/28\" class=\"abstract_t\">28</a>]. This observation has inspired efforts to use the SAECG to predict future arrhythmic risk.</p><p>Abnormalities in both time- and frequency-domain analyses are common in patients with a history of VT [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/34,36,67-69\" class=\"abstract_t\">34,36,67-69</a>]. Such abnormalities may occur at the terminal QRS, within the ST segment, or throughout the entire cardiac cycle [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/67\" class=\"abstract_t\">67</a>]. By contrast to time-domain analysis, the predictive accuracy of frequency-domain abnormalities is not affected by bundle branch block [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/68\" class=\"abstract_t\">68</a>]. This implies that the physiologic substrate critical to the initiation or maintenance of reentrant arrhythmias is independent of the deranged sequence or total duration of ventricular activation. SAECG abnormalities are less common in patients with a history of VF, demonstrable in only 21 to 65 percent of patients [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/70-72\" class=\"abstract_t\">70-72</a>], which may reflect pathophysiologic differences compared with VT. </p><p class=\"headingAnchor\" id=\"H3710208867\"><span class=\"h3\">Patients without prior VT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Due to the reduced rates of arrhythmic events in patients treated with contemporary reperfusion and medical therapies, the utility of the SAECG is limited in low-risk, unselected post-MI populations. As such, we do not routinely perform SAECG for risk stratification in all patients with ischemic heart disease without documented VT or VF. However, there may be a role for the SAECG in selected higher-risk, post-MI cohorts defined in conjunction with additional risk stratification tests, or for patients at high risk of complications from an ICD, in whom the absence of late potentials would impart a better prognosis and potentially shift the <span class=\"nowrap\">risk/benefit</span> ratio. (See <a href=\"topic.htm?path=incidence-of-and-risk-stratification-for-sudden-cardiac-death-after-acute-myocardial-infarction\" class=\"medical medical_review\">&quot;Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction&quot;</a>.)</p><p>Following an acute MI, the absence of late potentials on SAECG has a very high negative predictive accuracy (95 to 99 percent), but the presence of late potentials is associated with a low positive predictive accuracy (14 to 29 percent) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/39-41\" class=\"abstract_t\">39-41</a>]. Although the absence of late potentials on the SAECG indicates an excellent arrhythmia-free prognosis, their positive predictive accuracy is too low to guide therapy. Another limitation is that most of the data predate the use of contemporary therapies for acute MI that have been shown to improve outcome and reduce the rates of SCD (eg, rapid reperfusion, beta blockers, angiotensin converting enzyme inhibitors, statins). (See <a href=\"topic.htm?path=incidence-of-and-risk-stratification-for-sudden-cardiac-death-after-acute-myocardial-infarction\" class=\"medical medical_review\">&quot;Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction&quot;</a>.)</p><p>The positive predictive value of the SAECG is modest but improves considerably when combined with other risk factors including reduced left ventricular ejection fraction (LVEF), attenuated heart rate variability, high-grade ventricular ectopy, or inducible VT on electrophysiologic study (<a href=\"image.htm?imageKey=CARD%2F53211\" class=\"graphic graphic_table graphicRef53211 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/22,28,73-76\" class=\"abstract_t\">22,28,73-76</a>]. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one series of 102 post-MI patients, the combination of an abnormal T-wave alternans study and an abnormal SAECG had a positive predictive value for ventricular arrhythmias of 50 percent (<a href=\"image.htm?imageKey=CARD%2F51831\" class=\"graphic graphic_figure graphicRef51831 \">figure 5</a>) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/77\" class=\"abstract_t\">77</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the MUSTT trial, which enrolled 1925 patients with chronic coronary disease, left ventricular dysfunction, and asymptomatic nonsustained VT, an abnormal SAECG (filtered QRS duration &gt;114 milliseconds) was associated with a significantly increased risk of arrhythmic death or cardiac arrest, cardiac death, and total mortality [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/78\" class=\"abstract_t\">78</a>]. The combination of an abnormal SAECG and LVEF &lt;30 percent identified patients at highest risk for arrhythmic or cardiac death (<a href=\"image.htm?imageKey=CARD%2F66009\" class=\"graphic graphic_figure graphicRef66009 \">figure 6</a>). </p><p/><p>The optimal time at which to obtain the SAECG post-MI is uncertain, although it should be at least two to three weeks following the index MI. Late potentials are present within three hours of an acute MI in up to 52 percent of patients, and the incidence increases during the electrically unstable initial 24 to 48 hours post-MI. Although their prevalence decreases after this initial phase, late potentials recorded as early as 24 to 72 hours post-MI may portend increased risk for VT and VF [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/39\" class=\"abstract_t\">39</a>]. At 6 to 14 days post-MI, late potentials are detectable in up to 93 percent of patients who eventually develop VT or VF, particularly in the first six months [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/73,75\" class=\"abstract_t\">73,75</a>]. The detectability of late potentials falls over time, and when measured five years post-MI, late potentials are no longer seen in up to 50 percent of patients in whom they were detectable early after the infarction [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/40,41\" class=\"abstract_t\">40,41</a>]. It is uncertain whether the arrhythmic risk of these individuals diminishes compared with those in whom late potentials persist. </p><p>Among patients treated with thrombolytic therapy or primary percutaneous coronary intervention (PCI), the prevalence of SAECG abnormalities is lower (5 to 24 percent) than in patients with MI who are not reperfused (18 to 43 percent) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/79-94\" class=\"abstract_t\">79-94</a>]. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a substudy of a randomized trial of thrombolytic therapy in which 310 patients had an SAECG prior to discharge, the incidence of late potentials was 37 percent lower in patients assigned to thrombolytic therapy compared with placebo [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/95\" class=\"abstract_t\">95</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a cohort of 1800 survivors of acute MI, among whom 99 percent underwent primary reperfusion therapy (91 percent primary PCI), only 90 of 968 patients who had an SAECG (9.3 percent) were identified as having late potentials (ie, abnormal SAECG) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/86\" class=\"abstract_t\">86</a>]. Over a mean follow-up of 34 months, SAECG abnormalities did not correlate with the primary combined end point of cardiac death and arrhythmic events.</p><p/><p>Although primary reperfusion does not affect the physiologic basis of the SAECG, it is not known if the lower prevalence is due to reductions in infarct size or restoration of patency in the infarct-related artery [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/81,90,92,96,97\" class=\"abstract_t\">81,90,92,96,97</a>]. (See <a href=\"topic.htm?path=coronary-artery-patency-and-outcome-after-myocardial-infarction\" class=\"medical medical_review\">&quot;Coronary artery patency and outcome after myocardial infarction&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H623888023\"><span class=\"h2\">Nonischemic heart disease</span></p><p class=\"headingAnchor\" id=\"H4169264728\"><span class=\"h3\">Dilated cardiomyopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are conflicting data on the predictive value of the SAECG in patients with dilated nonischemic cardiomyopathy, with the SAECG being predictive of total mortality, cardiac death, <span class=\"nowrap\">and/or</span> arrhythmic events in some studies [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/98-100\" class=\"abstract_t\">98-100</a>] but not others [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/101-103\" class=\"abstract_t\">101-103</a>]. Given the inconsistent data, we do not routinely use the SAECG for risk stratification of patients with nonischemic cardiomyopathy.</p><p>As examples of the mixed data on SAECG in patients with dilated nonischemic cardiomyopathy:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a prospective study of 114 patients with nonischemic dilated cardiomyopathy, in which 20 of the 86 patients without bundle branch block had an abnormal SAECG, one-year survival free of VT was markedly better in patients with a normal SAECG (95 percent) compared with those with late potentials on the SAECG (39 percent) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/98\" class=\"abstract_t\">98</a>]. Similarly, a study of 131 patients with dilated cardiomyopathy followed for 54 months found that those with late potentials had an increased risk of all-cause cardiac death (relative risk [RR] 3.3, 95% CI 1.5-7.5) and arrhythmic events (RR 7.2, 95% CI 2.6-19.4) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/99\" class=\"abstract_t\">99</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Conversely, in a study of 343 patients with idiopathic dilated cardiomyopathy followed for 52 months, late potential on the SAECG did not predict arrhythmia risk or transplantation-free survival [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/102\" class=\"abstract_t\">102</a>]. Some studies have found that SAECG abnormalities are predictive of progressive heart failure in patients with dilated cardiomyopathy [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/104\" class=\"abstract_t\">104</a>].</p><p/><p class=\"headingAnchor\" id=\"H990601359\"><span class=\"h3\">Detection of cardiac allograft rejection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cardiac allograft rejection is characterized by myocardial inflammation followed by necrosis [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/105\" class=\"abstract_t\">105</a>]. Early studies suggested that the SAECG may be sensitive to disruptions in myocardial conduction caused by rejection, in addition to reductions in ECG voltage, conduction delay, and other ECG abnormalities that may occur despite immunosuppression [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/53,106,107\" class=\"abstract_t\">53,106,107</a>]. However, the SAECG is rarely used for this purpose in clinical practice.</p><p class=\"headingAnchor\" id=\"H602071469\"><span class=\"h2\">Arrhythmogenic right ventricular cardiomyopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the past, SAECG was considered a standard diagnostic test for ARVC [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/108\" class=\"abstract_t\">108</a>]. However, the importance of SAECG testing has declined considerably due to its limited sensitivity and specificity. Furthermore, SAECG testing is not available in many medical centers. However, when available, the SAECG is still considered a standard part of the diagnostic evaluation for ARVC. A detailed discussion of the role of SAECG in the diagnosis of ARVC is presented separately. (See <a href=\"topic.htm?path=arrhythmogenic-right-ventricular-cardiomyopathy-diagnostic-evaluation-and-diagnosis#H155582488\" class=\"medical medical_review\">&quot;Arrhythmogenic right ventricular cardiomyopathy: Diagnostic evaluation and diagnosis&quot;, section on 'Signal-averaged ECG'</a>.)</p><p class=\"headingAnchor\" id=\"H2554107086\"><span class=\"h2\">Brugada syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>SAECG is not performed in all patients with Brugada-pattern ECG findings, but it can be helpful when there is a high suspicion of Brugada syndrome but the diagnosis remains uncertain after other testing. Additionally, SAECG may be helpful in identifying a subset of patients at higher risk for VT and SCD. This is discussed in detail separately. (See <a href=\"topic.htm?path=brugada-syndrome-clinical-presentation-diagnosis-and-evaluation#H2490892010\" class=\"medical medical_review\">&quot;Brugada syndrome: Clinical presentation, diagnosis, and evaluation&quot;, section on 'Our approach to evaluation and risk stratification'</a>.)</p><p class=\"headingAnchor\" id=\"H544183726\"><span class=\"h2\">Late potentials and catheter ablation for ventricular tachycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We do not routinely perform SAECG in all patients with VT going for catheter ablation, but in select patients it can provide prognostic information. Some data support the prognostic utility of intracardiac late potentials in patients undergoing percutaneous catheter ablation, particularly in the SMASH-VT study, in which catheter ablation at regions of intraventricular late potentials reduced the incidence of ICD therapy on long-term follow-up [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/109\" class=\"abstract_t\">109</a>]. In a study of 18 patients with ARVC, elimination of late ventricular potentials by radiofrequency ablation predicted freedom from ventricular arrhythmias after a mean follow-up of five years [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/110\" class=\"abstract_t\">110</a>]. In two other studies, abnormal SAECG indices of ventricular depolarization were associated with cardiomyopathy in patients with right ventricular outflow tract-related ventricular arrhythmias, while epsilon waves in late depolarization and negative T waves were associated with the extent of ventricular scar on electroanatomic mapping [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/111,112\" class=\"abstract_t\">111,112</a>]. The clinical role of ventricular late potentials in these contexts is being actively investigated. (See <a href=\"topic.htm?path=invasive-cardiac-electrophysiology-studies\" class=\"medical medical_review\">&quot;Invasive cardiac electrophysiology studies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3803091927\"><span class=\"h2\">P-wave SAECG and atrial fibrillation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Reentrant arrhythmias in the atrium, analogous to those in the ventricle, also likely require heterogeneities in slow conduction and repolarization. This provides a theoretical basis for prediction of the propensity for AF by SAECG by examining slow conduction in the atrium, analogous to the detection of ventricular late potentials. However, further data are needed to clarify the role of P-wave SAECG before its widespread use can be recommended. (See <a href=\"topic.htm?path=reentry-and-the-development-of-cardiac-arrhythmias\" class=\"medical medical_review\">&quot;Reentry and the development of cardiac arrhythmias&quot;</a> and <a href=\"topic.htm?path=the-electrocardiogram-in-atrial-fibrillation\" class=\"medical medical_review\">&quot;The electrocardiogram in atrial fibrillation&quot;</a>.)</p><p>Patients with paroxysmal AF may be identified by P-wave prolongation on the SAECG during sinus rhythm, although the threshold P-wave duration that best discriminates such patients is controversial. A vector P-wave duration of 155 milliseconds predicted AF with a sensitivity, specificity, and positive predictive accuracy of 80, 93, and 92 percent, respectively [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/113\" class=\"abstract_t\">113</a>]. Unlike the ventricle, the utility of atrial late potentials in the terminal 10 to 20 milliseconds of the P wave remains controversial. It is also unclear whether low root mean square voltage at the P-wave terminus indicates AF risk independent of structural heart disease or left atrial dilatation [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/114,115\" class=\"abstract_t\">114,115</a>]. A biatrial mapping study showed that the site of AF initiation typically shows slow conduction at rapid rates, but not at baseline, just prior to AF onset [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/116\" class=\"abstract_t\">116</a>].</p><p>Data suggest that the development of AF can be predicted using analyses of the P wave from the SAECG in certain patient populations; for example, patients undergoing cardiac surgery, patients with a recent MI, and patients with hypertrophic cardiomyopathy (<a href=\"image.htm?imageKey=CARD%2F60431\" class=\"graphic graphic_figure graphicRef60431 \">figure 7</a>) [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/117-119\" class=\"abstract_t\">117-119</a>]. A substudy analysis of MADIT II found that abnormalities of P-wave shape in orthogonal X, Y, and Z axis ECGs predicted AF onset and SCA in 802 patients with ischemic cardiomyopathy and LVEF &le;30 percent [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/120\" class=\"abstract_t\">120</a>]. However, the traditional SAECG indices of P-wave duration and terminal amplitude did not predict AF onset or SCA. These results suggest a wider significance of the P wave than is generally recognized, perhaps as an indicator of atrial enlargement from ventricular dysfunction, and warrant further study. In a related study, P-wave morphology changed over time in patients from the MADIT II study who later developed AF, but remained unchanged in those who did not [<a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/121\" class=\"abstract_t\">121</a>]. </p><p class=\"headingAnchor\" id=\"H13310646\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Late potentials are primarily used to reflect the presence of substrates for ventricular tachycardia (VT) rather than a dynamic, time-varying predisposition to reentry. Although late potentials reflect slow conduction related to arrhythmogenic substrates, episodes of VT initiation in such patients are uncommon in the absence of additional triggers such as ventricular premature beats, electrolyte abnormalities, increased circulating catecholamines, or ischemia. (See <a href=\"#H2\" class=\"local\">'Definitions and epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The signal-averaged electrocardiogram (SAECG) is useful for detecting subtle abnormalities in the surface ECG that are not visible to the naked eye. One example of such an abnormality is the &quot;ventricular late potential,&quot; a low-amplitude signal near the end of the QRS complex that can be used to stratify risk for ventricular tachyarrhythmias in patients with cardiomyopathies of various etiologies. (See <a href=\"topic.htm?path=reentry-and-the-development-of-cardiac-arrhythmias\" class=\"medical medical_review\">&quot;Reentry and the development of cardiac arrhythmias&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The SAECG can be acquired by one of three methods (temporal signal averaging, spatial signal averaging, or spectral analysis), all with inherent benefits and limitations (see <a href=\"#H1256947621\" class=\"local\">'Techniques'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Temporal signal averaging, the most common method for obtaining the SAECG, averages a number of QRS complexes over time. </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Spatial signal averaging analyzes electrical potentials simultaneously recorded from multiple pairs of closely spaced electrodes. </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Spectral analysis considers the QRS complex (or P wave) to be composed of multiple simple waveforms, typically sinusoids. Spectral analysis thus decomposes the QRS complex (or P wave) into these constituent signals for analysis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The following time analyses, derived from temporal signal averaging, are the most frequently used criteria to define an abnormal SAECG (see <a href=\"#H1427388704\" class=\"local\">'Definition'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Filtered QRS duration &gt;114 milliseconds</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Terminal (last 40 milliseconds) QRS root mean square voltage &lt;20 microvolts</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Low-amplitude (&lt;40 microvolts) late potentials with duration &gt;38 milliseconds</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>SAECG abnormalities are associated with an increased risk of ventricular arrhythmias and cardiac and sudden death mortality in various clinical settings including post-myocardial infarction, ischemic cardiomyopathy, nonischemic cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and the Brugada syndrome. (See <a href=\"#H3\" class=\"local\">'Clinical settings'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ventricular late potentials on the intracardiac electrogram may represent critical sustaining mechanisms for VT and may be targeted for catheter ablation with successful arrhythmia elimination. (See <a href=\"#H544183726\" class=\"local\">'Late potentials and catheter ablation for ventricular tachycardia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The P-wave SAECG may indicate slow conduction in the atrium and in early work has been used to predict the propensity for atrial fibrillation. </p><p/><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/1\" class=\"nounderline abstract_t\">Bay&eacute;s de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117:151.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/2\" class=\"nounderline abstract_t\">Hood MA, Pogwizd SM, Peirick J, Cain ME. Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs. Circulation 1992; 86:1888.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/3\" class=\"nounderline abstract_t\">El-Sherif N, Scherlag BJ, Lazzara R, Hope RR. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone. Circulation 1977; 55:686.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/4\" class=\"nounderline abstract_t\">El-Sherif N, Hope RR, Scherlag BJ, Lazzara R. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 2. Patterns of initiation and termination of re-entry. Circulation 1977; 55:702.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/5\" class=\"nounderline abstract_t\">de Bakker JM, van Capelle FJ, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988; 77:589.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/6\" class=\"nounderline abstract_t\">Pogwizd SM, Hoyt RH, Saffitz JE, et al. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 1992; 86:1872.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/7\" class=\"nounderline abstract_t\">Ehlert FA, Steinberg JS. The P wave signal-averaged ECG. J Electrocardiol 1995; 28 Suppl:33.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/8\" class=\"nounderline abstract_t\">Abe Y, Fukunami M, Yamada T, et al. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation 1997; 96:2612.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/9\" class=\"nounderline abstract_t\">Liao YC, Lin YJ, Chung FP, et al. Risk stratification of arrhythmogenic right ventricular cardiomyopathy based on signal averaged electrocardiograms. Int J Cardiol 2014; 174:628.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/10\" class=\"nounderline abstract_t\">Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 1981; 64:235.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/11\" class=\"nounderline abstract_t\">Breithardt G, Cain ME, el-Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol 1991; 17:999.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/12\" class=\"nounderline abstract_t\">Richards DA, Blake GJ, Spear JF, Moore EN. Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. Circulation 1984; 69:369.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/13\" class=\"nounderline abstract_t\">Gardner PI, Ursell PC, Fenoglio JJ Jr, Wit AL. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985; 72:596.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/14\" class=\"nounderline abstract_t\">Breithardt G, Borggrefe M, Karbenn U, et al. Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings. Am J Cardiol 1982; 49:1932.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/15\" class=\"nounderline abstract_t\">Denes P, Santarelli P, Hauser RG, Uretz EF. Quantitative analysis of the high-frequency components of the terminal portion of the body surface QRS in normal subjects and in patients with ventricular tachycardia. Circulation 1983; 67:1129.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/16\" class=\"nounderline abstract_t\">Brugada P, Wellens HJ. Entrainment as an electrophysiologic phenomenon. J Am Coll Cardiol 1984; 3:451.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/17\" class=\"nounderline abstract_t\">Goldhammer E, Abinader EG. Circadian fluctuations of late potentials detected by signal-averaged electrocardiogram. Am Heart J 1996; 132:1298.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/18\" class=\"nounderline abstract_t\">Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/19\" class=\"nounderline abstract_t\">Kono T, Morita H, Nishina T, et al. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol 1996; 27:774.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/20\" class=\"nounderline abstract_t\">Kulakowski P, Malik M, Poloniecki J, et al. Frequency versus time domain analysis of signal-averaged electrocardiograms. II. Identification of patients with ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 1992; 20:135.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/21\" class=\"nounderline abstract_t\">Goldberger JJ, Ahmed MW, Parker MA, Kadish AH. Assessment of effects of autonomic stimulation and blockade on the signal-averaged electrocardiogram. Circulation 1994; 89:1656.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/22\" class=\"nounderline abstract_t\">Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991; 18:687.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/23\" class=\"nounderline abstract_t\">Farrell TG, Paul V, Cripps TR, et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 1991; 83:945.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/24\" class=\"nounderline abstract_t\">Kuchar DL, Thorburn CW, Freund J, et al. Noninvasive predictors of cardiac events after myocardial infarction. Complementary value of exercise testing and signal-averaged electrocardiography. Cardiology 1989; 76:18.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/25\" class=\"nounderline abstract_t\">Ja&iuml;s P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012; 125:2184.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/26\" class=\"nounderline abstract_t\">Berbari EJ, Scherlag BJ, Hope RR, Lazzara R. Recording from the body surface of arrhythmogenic ventricular activity during the S-T segment. Am J Cardiol 1978; 41:697.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/27\" class=\"nounderline abstract_t\">Berbari EJ, Lazzara R, Samet P, Scherlag BJ. Noninvasive technique for detection of electrical activity during the P-R segment. Circulation 1973; 48:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/28\" class=\"nounderline abstract_t\">Cain, ME, Anderson, et al. Signal-averaged electrocardiography. ACC Expert Consensus Document. J Am Coll Cardiol 1996; 27:238.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/29\" class=\"nounderline abstract_t\">Simson MB, Untereker WJ, Spielman SR, et al. Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia. Am J Cardiol 1983; 51:105.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/30\" class=\"nounderline abstract_t\">Narayan SM, Smith JM. Spectral analysis of periodic fluctuations in electrocardiographic repolarization. IEEE Trans Biomed Eng 1999; 46:203.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/31\" class=\"nounderline abstract_t\">Steinberg JS, Bigger JT Jr. Importance of the endpoint of noise reduction in analysis of the signal-averaged electrocardiogram. Am J Cardiol 1989; 63:556.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/32\" class=\"nounderline abstract_t\">El-Sherif N, Mehra R, Gomes JA, Kelen G. Appraisal of a Low Noise Electrocardiogram. J Am Coll Cardiol 1983; 1:456.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/33\" class=\"nounderline abstract_t\">He B, Cohen RJ. Body surface Laplacian electrocardiographic mapping--a review. Crit Rev Biomed Eng 1995; 23:475.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/34\" class=\"nounderline abstract_t\">Kavesh NG, Cain ME, Ambos HD, Arthur RM. Enhanced detection of distinguishing features in signal-averaged electrocardiograms from patients with ventricular tachycardia by combined spatial and spectral analyses of entire cardiac cycle. Circulation 1994; 90:254.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/35\" class=\"nounderline abstract_t\">SippensGroenewegen A, Lesh MD, Roithinger FX, et al. Body surface mapping of counterclockwise and clockwise typical atrial flutter: a comparative analysis with endocardial activation sequence mapping. J Am Coll Cardiol 2000; 35:1276.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/36\" class=\"nounderline abstract_t\">Cain ME, Ambos HD, Witkowski FX, Sobel BE. Fast-Fourier transform analysis of signal-averaged electrocardiograms for identification of patients prone to sustained ventricular tachycardia. Circulation 1984; 69:711.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/37\" class=\"nounderline abstract_t\">Machac J, Weiss A, Winters SL, et al. A comparative study of frequency domain and time domain analysis of signal-averaged electrocardiograms in patients with ventricular tachycardia. J Am Coll Cardiol 1988; 11:284.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/38\" class=\"nounderline abstract_t\">Haberl R, Jilge G, Pulter R, Steinbeck G. Spectral mapping of the electrocardiogram with Fourier transform for identification of patients with sustained ventricular tachycardia and coronary artery disease. Eur Heart J 1989; 10:316.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/39\" class=\"nounderline abstract_t\">McGuire M, Kuchar D, Ganis J, et al. Natural history of late potentials in the first ten days after acute myocardial infarction and relation to early ventricular arrhythmias. Am J Cardiol 1988; 61:1187.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/40\" class=\"nounderline abstract_t\">Kuchar DL, Thorburn CW, Sammel NL. Late potentials detected after myocardial infarction: natural history and prognostic significance. Circulation 1986; 74:1280.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/41\" class=\"nounderline abstract_t\">Denniss AR, Ross DL, Richards DA, Uther JB. Changes in ventricular activation time on the signal-averaged electrocardiogram in the first year after acute myocardial infarction. Am J Cardiol 1987; 60:580.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/42\" class=\"nounderline abstract_t\">Middlekauff HR, Stevenson WG, Woo MA, et al. Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol 1990; 66:1113.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/43\" class=\"nounderline abstract_t\">Poll DS, Marchlinski FE, Falcone RA, et al. Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias. Circulation 1985; 72:1308.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/44\" class=\"nounderline abstract_t\">Cripps TR, Counihan PJ, Frenneaux MP, et al. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15:956.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/45\" class=\"nounderline abstract_t\">Peeters HA, SippensGroenewegen A, Schoonderwoerd BA, et al. Body-surface QRST integral mapping. Arrhythmogenic righ ventricular dysplasia versus idiopathic right ventricular tachycardia. Circulation 1997; 95:2668.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/46\" class=\"nounderline abstract_t\">Kinoshita O, Fontaine G, Rosas F, et al. Time- and frequency-domain analyses of the signal-averaged ECG in patients with arrhythmogenic right ventricular dysplasia. Circulation 1995; 91:715.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/47\" class=\"nounderline abstract_t\">Blomstr&ouml;m-Lundqvist C, Hirsch I, Olsson SB, Edvardsson N. Quantitative analysis of the signal-averaged QRS in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J 1988; 9:301.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/48\" class=\"nounderline abstract_t\">Blomstr&ouml;m-Lundqvist C, Olsson SB, Edvardsson N. Follow-up by repeated signal-averaged surface QRS in patients with the syndrome of arrhythmogenic right ventricular dysplasia. Eur Heart J 1989; 10 Suppl D:54.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/49\" class=\"nounderline abstract_t\">Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001; 37:1628.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/50\" class=\"nounderline abstract_t\">Furushima H, Chinushi M, Hirono T, et al. Relationship between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome. J Cardiovasc Electrophysiol 2005; 16:1311.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/51\" class=\"nounderline abstract_t\">Tatsumi H, Takagi M, Nakagawa E, et al. Risk stratification in patients with Brugada syndrome: analysis of daily fluctuations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG). J Cardiovasc Electrophysiol 2006; 17:705.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/52\" class=\"nounderline abstract_t\">Lacroix D, Kacet S, Savard P, et al. Signal-averaged electrocardiography and detection of heart transplant rejection: comparison of time and frequency domain analyses. J Am Coll Cardiol 1992; 19:553.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/53\" class=\"nounderline abstract_t\">Keren A, Gillis AM, Freedman RA, et al. Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine. Circulation 1984; 70:I124.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/54\" class=\"nounderline abstract_t\">Vacek JL, Wilson DB, Botteron GW, Dobbins J. Techniques for the determination of left ventricular mass by signal-averaged electrocardiography. Am Heart J 1990; 120:958.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/55\" class=\"nounderline abstract_t\">Raineri AA, Traina M, Lombardo RM, Rotolo A. Relation between late potentials and echocardiographically determined left ventricular mass in healthy subjects. Am J Cardiol 1991; 67:425.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/56\" class=\"nounderline abstract_t\">Pringle SD, Dunn FG, Macfarlane PW, et al. Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1992; 69:913.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/57\" class=\"nounderline abstract_t\">Yotsukura M, Ishizuka T, Shimada T, Ishikawa K. Late potentials in progressive muscular dystrophy of the Duchenne type. Am Heart J 1991; 121:1137.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/58\" class=\"nounderline abstract_t\">Milner MR, Hawley RJ, Jachim M, et al. Ventricular late potentials in myotonic dystrophy. Ann Intern Med 1991; 115:607.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/59\" class=\"nounderline abstract_t\">Moser DK, Stevenson WG, Woo MA, et al. Frequency of late potentials in systemic sclerosis. Am J Cardiol 1991; 67:541.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/60\" class=\"nounderline abstract_t\">Yang Q, Kiyoshige K, Fujimoto T, et al. Signal-averaging electrocardiogram in patients with diabetes mellitus. Jpn Heart J 1990; 31:25.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/61\" class=\"nounderline abstract_t\">de Leonardis V, Bartalucci S, Cinelli P, et al. Ventricular late potentials in the assessment of mitoxantrone cardiotoxicity. Cardiology 1991; 79:110.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/62\" class=\"nounderline abstract_t\">Hsia J, Colan SD, Adams S, Ross AM. Late potentials and their relation to ventricular function in human immunodeficiency virus infection. Am J Cardiol 1991; 68:1216.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/63\" class=\"nounderline abstract_t\">Stelling JA, Danford DA, Kugler JD, et al. Late potentials and inducible ventricular tachycardia in surgically repaired congenital heart disease. Circulation 1990; 82:1690.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/64\" class=\"nounderline abstract_t\">Zimmermann M, Friedli B, Adamec R, Oberh&auml;nsli I. Ventricular late potentials and induced ventricular arrhythmias after surgical repair of tetralogy of Fallot. Am J Cardiol 1991; 67:873.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/65\" class=\"nounderline abstract_t\">Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008; 118:1497.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/66\" class=\"nounderline abstract_t\">European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:e247.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/67\" class=\"nounderline abstract_t\">Cain ME, Ambos HD, Markham J, et al. Diagnostic implications of spectral and temporal analysis of the entire cardiac cycle in patients with ventricular tachycardia. Circulation 1991; 83:1637.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/68\" class=\"nounderline abstract_t\">Lindsay BD, Markham J, Schechtman KB, et al. Identification of patients with sustained ventricular tachycardia by frequency analysis of signal-averaged electrocardiograms despite the presence of bundle branch block. Circulation 1988; 77:122.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/69\" class=\"nounderline abstract_t\">Lindsay BD, Ambos HD, Schechtman KB, et al. Noninvasive detection of patients with ischemic and nonischemic heart disease prone to ventricular fibrillation. J Am Coll Cardiol 1990; 16:1656.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/70\" class=\"nounderline abstract_t\">Denniss AR, Ross DL, Richards DA, et al. Differences between patients with ventricular tachycardia and ventricular fibrillation as assessed by signal-averaged electrocardiogram, radionuclide ventriculography and cardiac mapping. J Am Coll Cardiol 1988; 11:276.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/71\" class=\"nounderline abstract_t\">Martinez-Rubio A, Shenasa M, Borggrefe M, et al. Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction: relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1993; 21:1624.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/72\" class=\"nounderline abstract_t\">Freedman RA, Gillis AM, Keren A, et al. Signal-averaged electrocardiographic late potentials in patients with ventricular fibrillation or ventricular tachycardia: correlation with clinical arrhythmia and electrophysiologic study. Am J Cardiol 1985; 55:1350.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/73\" class=\"nounderline abstract_t\">Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol 1987; 9:531.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/74\" class=\"nounderline abstract_t\">el-Sherif N, Denes P, Katz R, et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. J Am Coll Cardiol 1995; 25:908.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/75\" class=\"nounderline abstract_t\">Denniss AR, Richards DA, Cody DV, et al. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 1986; 74:731.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/76\" class=\"nounderline abstract_t\">Pedretti R, Etro MD, Laporta A, et al. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993; 71:1131.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/77\" class=\"nounderline abstract_t\">Ikeda T, Sakata T, Takami M, et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000; 35:722.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/78\" class=\"nounderline abstract_t\">Gomes JA, Cain ME, Buxton AE, et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001; 104:436.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/79\" class=\"nounderline abstract_t\">Turitto G, Risa AL, Zanchi E, Prati PL. The signal-averaged electrocardiogram and ventricular arrhythmias after thrombolysis for acute myocardial infarction. J Am Coll Cardiol 1990; 15:1270.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/80\" class=\"nounderline abstract_t\">Pedretti R, Laporta A, Etro MD, et al. Influence of thrombolysis on signal-averaged electrocardiogram and late arrhythmic events after acute myocardial infarction. Am J Cardiol 1992; 69:866.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/81\" class=\"nounderline abstract_t\">Zimmermann M, Adamec R, Ciaroni S. Reduction in the frequency of ventricular late potentials after acute myocardial infarction by early thrombolytic therapy. Am J Cardiol 1991; 67:697.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/82\" class=\"nounderline abstract_t\">Gang ES, Lew AS, Hong M, et al. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med 1989; 321:712.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/83\" class=\"nounderline abstract_t\">Hohnloser SH, Gersh BJ. Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator. Circulation 2003; 107:941.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/84\" class=\"nounderline abstract_t\">Malik M, Kulakowski P, Odemuyiwa O, et al. Effect of thrombolytic therapy on the predictive value of signal-averaged electrocardiography after acute myocardial infarction. Am J Cardiol 1992; 70:21.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/85\" class=\"nounderline abstract_t\">Savard P, Rouleau JL, Ferguson J, et al. Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation 1997; 96:202.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/86\" class=\"nounderline abstract_t\">Bauer A, Guzik P, Barthel P, et al. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J 2005; 26:755.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/87\" class=\"nounderline abstract_t\">Denes P, el-Sherif N, Katz R, et al. Prognostic significance of signal-averaged electrocardiogram after thrombolytic therapy and/or angioplasty during acute myocardial infarction (CAST substudy). Cardiac Arrhythmia Suppression Trial (CAST) SAECG Substudy Investigators. Am J Cardiol 1994; 74:216.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/88\" class=\"nounderline abstract_t\">Eldar M, Leor J, Hod H, et al. Effect of thrombolysis on the evolution of late potentials within 10 days of infarction. Br Heart J 1990; 63:273.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/89\" class=\"nounderline abstract_t\">Tranchesi B Jr, Verstraete M, Van de Werf F, et al. Usefulness of high-frequency analysis of signal-averaged surface electrocardiograms in acute myocardial infarction before and after coronary thrombolysis for assessing coronary reperfusion. Am J Cardiol 1990; 66:1196.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/90\" class=\"nounderline abstract_t\">Aguirre FV, Kern MJ, Hsia J, et al. Importance of myocardial infarct artery patency on the prevalence of ventricular arrhythmia and late potentials after thrombolysis in acute myocardial infarction. Am J Cardiol 1991; 68:1410.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/91\" class=\"nounderline abstract_t\">Santarelli P, Lanza GA, Biscione F, et al. Effects of thrombolysis and atenolol or metoprolol on the signal-averaged electrocardiogram after acute myocardial infarction. Late Potentials Italian Study (LAPIS). Am J Cardiol 1993; 72:525.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/92\" class=\"nounderline abstract_t\">Hermosillo AG, Dorado M, Casanova JM, et al. Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction. J Am Coll Cardiol 1993; 22:695.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/93\" class=\"nounderline abstract_t\">de Chillou C, Sadoul N, Brian&ccedil;on S, Aliot E. Factors determining the occurrence of late potentials on the signal-averaged electrocardiogram after a first myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1991; 18:1638.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/94\" class=\"nounderline abstract_t\">Karam C, Golmard J, Steg PG. Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarction. J Am Coll Cardiol 1996; 27:1343.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/95\" class=\"nounderline abstract_t\">Steinberg JS, Hochman JS, Morgan CD, et al. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation 1994; 90:746.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/96\" class=\"nounderline abstract_t\">Ragosta M, Sabia PJ, Kaul S, et al. Effects of late (1 to 30 days) reperfusion after acute myocardial infarction on the signal-averaged electrocardiogram. Am J Cardiol 1993; 71:19.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/97\" class=\"nounderline abstract_t\">Boehrer JD, Glamann DB, Lange RA, et al. Effect of coronary angioplasty on late potentials one to two weeks after acute myocardial infarction. Am J Cardiol 1992; 70:1515.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/98\" class=\"nounderline abstract_t\">Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993; 87:1083.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/99\" class=\"nounderline abstract_t\">Fauchier L, Babuty D, Cosnay P, et al. Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 85:618.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/100\" class=\"nounderline abstract_t\">Goedel-Meinen L, Hofmann M, Ryba S, Sch&ouml;mig A. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy. Am J Cardiol 2001; 87:809.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/101\" class=\"nounderline abstract_t\">Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, et al. The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. Am J Cardiol 1997; 79:154.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/102\" class=\"nounderline abstract_t\">Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003; 108:2883.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/103\" class=\"nounderline abstract_t\">Hohnloser SH, Klingenheben T, Bloomfield D, et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 2003; 41:2220.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/104\" class=\"nounderline abstract_t\">Yi G, Keeling PJ, Goldman JH, et al. Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1995; 75:494.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/105\" class=\"nounderline abstract_t\">Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9:587.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/106\" class=\"nounderline abstract_t\">Cooper DK, Charles RG, Rose AG, et al. Does the electrocardiogram detect early acute heart rejection. J Heart Transplant 1985; 4:546.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/107\" class=\"nounderline abstract_t\">Eckart RE, Kolasa MW, Khan NA, et al. Surface electrocardiography and histologic rejection following orthotopic heart transplantation. Ann Noninvasive Electrocardiol 2005; 10:60.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/108\" class=\"nounderline abstract_t\">Kamath GS, Zareba W, Delaney J, et al. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2011; 8:256.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/109\" class=\"nounderline abstract_t\">Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357:2657.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/110\" class=\"nounderline abstract_t\">Oginosawa Y, Nogami A, Soejima K, et al. Effect of cardiac resynchronization therapy in isolated ventricular noncompaction in adults: follow-up of four cases. J Cardiovasc Electrophysiol 2008; 19:935.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/111\" class=\"nounderline abstract_t\">Santangeli P, Di Biase L, Horton R, et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis. Circ Arrhythm Electrophysiol 2012; 5:302.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/112\" class=\"nounderline abstract_t\">Zorzi A, Migliore F, Elmaghawry M, et al. Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol 2013; 24:1321.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/113\" class=\"nounderline abstract_t\">Guidera SA, Steinberg JS. The signal-averaged P wave duration: a rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993; 21:1645.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/114\" class=\"nounderline abstract_t\">Fukunami M, Yamada T, Ohmori M, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991; 83:162.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/115\" class=\"nounderline abstract_t\">Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 1991; 68:751.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/116\" class=\"nounderline abstract_t\">Lalani GG, Schricker A, Gibson M, et al. Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation. J Am Coll Cardiol 2012; 59:595.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/117\" class=\"nounderline abstract_t\">Klein M, Evans SJ, Blumberg S, et al. Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J 1995; 129:895.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/118\" class=\"nounderline abstract_t\">Zaman AG, Archbold RA, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000; 101:1403.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/119\" class=\"nounderline abstract_t\">Cecchi F, Montereggi A, Olivotto I, et al. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration. Heart 1997; 78:44.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/120\" class=\"nounderline abstract_t\">Holmqvist F, Platonov PG, McNitt S, et al. Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients. Ann Noninvasive Electrocardiol 2010; 15:63.</a></li><li><a href=\"https://www.uptodate.com/contents/signal-averaged-electrocardiogram-overview-of-technical-aspects-and-clinical-applications/abstract/121\" class=\"nounderline abstract_t\">Holmqvist F, Platonov PG, Carlson J, et al. Altered interatrial conduction detected in MADIT II patients bound to develop atrial fibrillation. Ann Noninvasive Electrocardiol 2009; 14:268.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 984 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H13310646\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">DEFINITIONS AND EPIDEMIOLOGY</a><ul><li><a href=\"#H1427388704\" id=\"outline-link-H1427388704\">Definition</a></li><li><a href=\"#H3410181775\" id=\"outline-link-H3410181775\">Epidemiology</a></li></ul></li><li><a href=\"#H3598201842\" id=\"outline-link-H3598201842\">MECHANISM OF VENTRICULAR ARRHYTHMIAS DUE TO LATE POTENTIALS</a></li><li><a href=\"#H1256947621\" id=\"outline-link-H1256947621\">TECHNIQUES</a><ul><li><a href=\"#H3400462\" id=\"outline-link-H3400462\">Acquiring the data</a></li><li><a href=\"#H1270124523\" id=\"outline-link-H1270124523\">Temporal signal averaging</a></li><li><a href=\"#H355085444\" id=\"outline-link-H355085444\">Spatial signal averaging</a></li><li><a href=\"#H1026286081\" id=\"outline-link-H1026286081\">Other techniques</a></li></ul></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL SETTINGS</a><ul><li><a href=\"#H1059290742\" id=\"outline-link-H1059290742\">Ischemic heart disease</a><ul><li><a href=\"#H4277501083\" id=\"outline-link-H4277501083\">- Patients with prior VT</a></li><li><a href=\"#H3710208867\" id=\"outline-link-H3710208867\">- Patients without prior VT</a></li></ul></li><li><a href=\"#H623888023\" id=\"outline-link-H623888023\">Nonischemic heart disease</a><ul><li><a href=\"#H4169264728\" id=\"outline-link-H4169264728\">- Dilated cardiomyopathy</a></li><li><a href=\"#H990601359\" id=\"outline-link-H990601359\">- Detection of cardiac allograft rejection</a></li></ul></li><li><a href=\"#H602071469\" id=\"outline-link-H602071469\">Arrhythmogenic right ventricular cardiomyopathy</a></li><li><a href=\"#H2554107086\" id=\"outline-link-H2554107086\">Brugada syndrome</a></li><li><a href=\"#H544183726\" id=\"outline-link-H544183726\">Late potentials and catheter ablation for ventricular tachycardia</a></li><li><a href=\"#H3803091927\" id=\"outline-link-H3803091927\">P-wave SAECG and atrial fibrillation</a></li></ul></li><li><a href=\"#H13310646\" id=\"outline-link-H13310646\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"CARD/984|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/72380\" class=\"graphic graphic_figure\">- Positive SAECG following myocardial infarction</a></li><li><a href=\"image.htm?imageKey=CARD/82329\" class=\"graphic graphic_figure\">- Late potentials in diastole</a></li><li><a href=\"image.htm?imageKey=CARD/75403\" class=\"graphic graphic_figure\">- QRS alignment methods</a></li><li><a href=\"image.htm?imageKey=CARD/70822\" class=\"graphic graphic_figure\">- Late potentials in ARVC</a></li><li><a href=\"image.htm?imageKey=CARD/51831\" class=\"graphic graphic_figure\">- TW alternans and late potentials predict arrhythmias</a></li><li><a href=\"image.htm?imageKey=CARD/66009\" class=\"graphic graphic_figure\">- Positive SAECG predicts outcomes with NSVT</a></li><li><a href=\"image.htm?imageKey=CARD/60431\" class=\"graphic graphic_figure\">- SAECG predicts atrial fibrillation post CABG</a></li></ul></li><li><div id=\"CARD/984|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/80458\" class=\"graphic graphic_table\">- Noninvasive methods for arrhythmia risk stratification after MI</a></li><li><a href=\"image.htm?imageKey=CARD/53211\" class=\"graphic graphic_table\">- SAECG and VT after MI</a></li></ul></li><li><div id=\"CARD/984|Waveform\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"WAVEFORMS\">WAVEFORMS</a></div><ul><li><a href=\"image.htm?imageKey=CARD/67428\" class=\"graphic graphic_waveform\">- Computing SAECG</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-cardiac-allograft-rejection-diagnosis\" class=\"medical medical_review\">Acute cardiac allograft rejection: Diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=arrhythmogenic-right-ventricular-cardiomyopathy-diagnostic-evaluation-and-diagnosis\" class=\"medical medical_review\">Arrhythmogenic right ventricular cardiomyopathy: Diagnostic evaluation and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=brugada-syndrome-clinical-presentation-diagnosis-and-evaluation\" class=\"medical medical_review\">Brugada syndrome: Clinical presentation, diagnosis, and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=coronary-artery-patency-and-outcome-after-myocardial-infarction\" class=\"medical medical_review\">Coronary artery patency and outcome after myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=incidence-of-and-risk-stratification-for-sudden-cardiac-death-after-acute-myocardial-infarction\" class=\"medical medical_review\">Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=invasive-cardiac-electrophysiology-studies\" class=\"medical medical_review\">Invasive cardiac electrophysiology studies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-and-etiology-of-sudden-cardiac-arrest\" class=\"medical medical_review\">Pathophysiology and etiology of sudden cardiac arrest</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=reentry-and-the-development-of-cardiac-arrhythmias\" class=\"medical medical_review\">Reentry and the development of cardiac arrhythmias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sustained-monomorphic-ventricular-tachycardia-clinical-manifestations-diagnosis-and-evaluation\" class=\"medical medical_review\">Sustained monomorphic ventricular tachycardia: Clinical manifestations, diagnosis, and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=t-wave-repolarization-alternans-technical-aspects\" class=\"medical medical_review\">T wave (repolarization) alternans: Technical aspects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-electrocardiogram-in-atrial-fibrillation\" class=\"medical medical_review\">The electrocardiogram in atrial fibrillation</a></li></ul></div></div>","javascript":null}